美国实验室业绩爆表_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":806749118,"tweetId":"806749118","gmtCreate":1627696334134,"gmtModify":1627696334134,"author":{"id":3452938437060827,"authorId":3452938437060827,"authorIdStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[{"themeId":"3dedd76b82b147d9878afe8793c4b4c8","categoryId":"7ba93224048e4975aa9a5a60d7f2353b","name":"下一个美股打新，会是大肉签吗？","type":3,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/discussion&rndata={\"themeId\":3dedd76b82b147d9878afe8793c4b4c8}&rnconfig={\"headerBarHidden\": true}","description":"药明康德、红杉资本等投资的天演药业和SaaS第一中概股容联云将在本月上市，2020年上市的中概股表现优异，这两家你看好吗？","image":"https://static.tigerbbs.com/109478ac79e7b1010aba611ffde0b0b2"}],"images":[],"coverImages":[],"title":"美国实验室业绩爆表","extraTitle":"","html":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/LH\">$实验美控(LH)$</a>&nbsp;的二季度收入跃升39%，并提高了全年收入、每股收益和现金流的指导。该公司表示，COVID-19 Delta变异的激增有助于推动下半年比预期好得多的增长，7月份PCR数量加速回到第二季度平均约54000/天。该公司目前偏向于2021年每股收益的高端预期。该公司表示，LabCorp将2021年的自由现金流提升至20.5亿美元（约为大流行前水平的两倍），但上半年仅将其中约4亿美元用于回购和并购；这将大大促进下半年的部署。不少分析师将该公司推高至新的价格目标345美元，意味着上涨16.5%。 <a target=\"_blank\" href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/LI\">$理想汽车(LI)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/VIPS\">$唯品会(VIPS)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/MOMO\">$陌陌(MOMO)$</a>&nbsp; </body></html>","htmlText":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/LH\">$实验美控(LH)$</a>&nbsp;的二季度收入跃升39%，并提高了全年收入、每股收益和现金流的指导。该公司表示，COVID-19 Delta变异的激增有助于推动下半年比预期好得多的增长，7月份PCR数量加速回到第二季度平均约54000/天。该公司目前偏向于2021年每股收益的高端预期。该公司表示，LabCorp将2021年的自由现金流提升至20.5亿美元（约为大流行前水平的两倍），但上半年仅将其中约4亿美元用于回购和并购；这将大大促进下半年的部署。不少分析师将该公司推高至新的价格目标345美元，意味着上涨16.5%。 <a target=\"_blank\" href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/LI\">$理想汽车(LI)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/VIPS\">$唯品会(VIPS)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/MOMO\">$陌陌(MOMO)$</a>&nbsp; </body></html>","text":"$实验美控(LH)$ 的二季度收入跃升39%，并提高了全年收入、每股收益和现金流的指导。 该公司表示，COVID-19 Delta变异的激增有助于推动下半年比预期好得多的增长，7月份PCR数量加速回到第二季度平均约54000/天。 该公司目前偏向于2021年每股收益的高端预期。该公司表示，LabCorp将2021年的自由现金流提升至20.5亿美元（约为大流行前水平的两倍），但上半年仅将其中约4亿美元用于回购和并购；这将大大促进下半年的部署。 不少分析师将该公司推高至新的价格目标345美元，意味着上涨16.5%。 $金斯瑞生物科技(01548)$ $理想汽车(LI)$ $唯品会(VIPS)$ $陌陌(MOMO)$","highlighted":1,"essential":1,"paper":2,"likeSize":7,"commentSize":1,"repostSize":1,"favoriteSize":0,"link":"https://laohu8.com/post/806749118","repostId":0,"isVote":1,"tweetType":1,"viewCount":6086,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["MOMO","LH","01548","LI","VIPS"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":494,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":5385353,"gmtCreate":1627697736979,"gmtModify":1627697736979,"authorId":3580432238496645,"author":{"id":3580432238496645,"authorId":3580432238496645,"name":"小虎北极熊","avatar":"https://static.tigerbbs.com/05881c41cbde8a82e60d78c4c0a07886","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":806749118,"type":1,"supId":0,"prevId":0,"content":"美国实验室研究些什么？","text":"美国实验室研究些什么？","html":"美国实验室研究些什么？","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

美国实验室业绩爆表

评论（1）

热议股票